Goilav Beatrice, Norton Karen I, Satlin Lisa M, Guay-Woodford Lisa, Chen Frank, Magid Margret S, Emre Sukru, Shneider Benjamin L
Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA.
Pediatr Transplant. 2006 May;10(3):294-8. doi: 10.1111/j.1399-3046.2005.00456.x.
Autosomal recessive polycystic kidney disease (ARPKD) is characterized by dilation of ectatic renal collecting ducts, intrahepatic biliary dysgenesis, and portal fibrosis. Portal hypertension and recurrent bacterial cholangitis can dominate the clinical picture in long-term survivors. Predominant extrahepatic bile duct disease was revealed in four patients who underwent magnetic resonance cholangiopancreatography. All four patients had portal hypertension, although liver biochemistries did not suggest biliary disease. In two of the patients, cholangitis was clinically ascribed to the bile duct disease. Western blot analysis of plasma membranes from normal rat extrahepatic bile duct and kidney revealed the presence of polyductin as a single approximately 440 kDa protein. Although the exact function of polyductin in the extrahepatic duct is unknown, it may have a role in the development and control of lumenal size. Clinical management of patients with ARPKD should include consideration of potential problems related to extrahepatic bile duct disease.
常染色体隐性多囊肾病(ARPKD)的特征为扩张的肾集合管、肝内胆管发育异常及门静脉纤维化。门静脉高压和复发性细菌性胆管炎在长期存活者中可成为主要临床表现。在接受磁共振胰胆管造影的4例患者中发现以肝外胆管疾病为主。所有4例患者均有门静脉高压,尽管肝脏生化检查未提示胆管疾病。其中2例患者临床上将胆管炎归因于胆管疾病。对正常大鼠肝外胆管和肾脏的质膜进行蛋白质印迹分析,结果显示存在一种单一的约440 kDa的多导管蛋白。尽管多导管蛋白在肝外胆管的确切功能尚不清楚,但它可能在管腔大小的发育和控制中起作用。ARPKD患者的临床管理应包括考虑与肝外胆管疾病相关的潜在问题。